Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Disease Characteristics Influence the Privacy Calculus to adopt Electronic Health Records: A randomized controlled trial in Germany

View ORCID ProfileNiklas von Kalckreuth, View ORCID ProfileMarkus Feufel
doi: https://doi.org/10.1101/2024.02.07.24302380
Niklas von Kalckreuth
1Department of Psychology and Ergonomics (IPA), Technische Universität Berlin, Straße des 17. Juni 135, 10623 Berlin, Germany
M.Sc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Niklas von Kalckreuth
  • For correspondence: niklas.vkalckreuth{at}tu-berlin.de markus.feufel{at}tu-berlin.de
Markus Feufel
1Department of Psychology and Ergonomics (IPA), Technische Universität Berlin, Straße des 17. Juni 135, 10623 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Markus Feufel
  • For correspondence: niklas.vkalckreuth{at}tu-berlin.de markus.feufel{at}tu-berlin.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The electronic health record (EHR) is integral to improving healthcare efficiency and quality. Its successful implementation hinges on patient willingness to use it, particularly in Germany where concerns about data security and privacy significantly influence usage intention. Little is known, however, about how specific characteristics of medical data influence patients’ intention to use the EHR.

Objective This study aims to validate the Privacy Calculus Model (PCM) in the EHR context and to assess how personal and disease characteristics, namely disease-related stigma and disease time course, affect PCM predictions.

Methods An online survey was conducted to empirically validate the PCM for EHR, incorporating a case vignette varying in disease-related stigma (high/low) and time course (acute/chronic), with 241 German participants. The data were analyzed using SEM-PLS.

Results The model explains R²=71.8% of the variance in intention to use. The intention to use is influenced by perceived benefits, data privacy concerns, trust in the provider, and social norms. However, only the disease’s time course, not stigma, affects this intention. For acute diseases, perceived benefits and social norms are influential, whereas for chronic diseases, perceived benefits, privacy concerns, and trust in the provider influence intention.

Conclusions The PCM validation for EHRs reveals that personal and disease characteristics shape usage intention in Germany. This suggests the need for tailored EHR adoption strategies that address specific needs and concerns of patients with different disease types. Such strategies could lead to a more successful and widespread implementation of EHRs, especially in privacy-conscious contexts.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors received no financial support for the research and/or authorship of this article. We also thank the evangelisches Studienwerk Villigst and the German Federal Ministry of Education and Research, who provided the doctoral scholarship (NvK) without which this research would not have been possible.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This Ethics Committee of the Department of Psychology and Ergonomics (Institut fuer Psychologie und Arbeitswissenschaft [IPA]) at Technische Universitaet Berlin approved this study (tracking number: AWB_KAL_1_230311).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

  • Abbreviations

    AP
    attitude to privacy
    AVE
    average variance extracted
    CON
    perceived control over personal data
    CONSORT
    consolidated standards of reporting trails
    CR
    composite reliability
    EHR
    electronic health record
    HTMT
    heterotrait-monotrait ratio of correlations
    IoT
    internet of things
    IU
    intention to use
    IV
    independent variable
    M
    mean
    MGA
    multigroup analysis
    mHealth
    mobile health
    OR
    odds ratio
    PB
    perceived benefits
    PC
    privacy concerns
    R²
    coefficient of determination
    SD
    standard deviation
    SEM
    structural equation modeling
    SEM-PLS
    structural equation modeling with partial least squares
    SN
    social norm
    SNS
    social network site
    SP
    stigmatization potential
    STD
    sexually transmitted disease
    TC
    time course
    TP
    trust in the provider
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted February 08, 2024.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Disease Characteristics Influence the Privacy Calculus to adopt Electronic Health Records: A randomized controlled trial in Germany
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Disease Characteristics Influence the Privacy Calculus to adopt Electronic Health Records: A randomized controlled trial in Germany
    Niklas von Kalckreuth, Markus Feufel
    medRxiv 2024.02.07.24302380; doi: https://doi.org/10.1101/2024.02.07.24302380
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Disease Characteristics Influence the Privacy Calculus to adopt Electronic Health Records: A randomized controlled trial in Germany
    Niklas von Kalckreuth, Markus Feufel
    medRxiv 2024.02.07.24302380; doi: https://doi.org/10.1101/2024.02.07.24302380

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Health Informatics
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)